Compile Data Set for Download or QSAR
Found 225 with Last Name = 'jenkins' and Initial = 'je'
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50234380(CHEMBL245876 | quinolin-8-yl 4-methyl-3-(piperidin...)copy SMILEScopy InChI
Affinity DataKi:  3nMAssay Description:Displacement of [3H]CP55940 from human CB1 receptor expressed in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X92B1FPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50234380(CHEMBL245876 | quinolin-8-yl 4-methyl-3-(piperidin...)copy SMILEScopy InChI
Affinity DataKi:  4nMAssay Description:Displacement of [3H]CP55940 from human CB2 receptor expressed in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X92B1FPubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataIC50: 630nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C8(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042591(CHEMBL3353862)copy SMILEScopy InChI
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C8(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042700(CHEMBL3353881)copy SMILEScopy InChI
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042700(CHEMBL3353881)copy SMILEScopy InChI
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042591(CHEMBL3353862)copy SMILEScopy InChI
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C8(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042700(CHEMBL3353881)copy SMILEScopy InChI
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042591(CHEMBL3353862)copy SMILEScopy InChI
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50341023(CHEMBL1762293 | N-(5-tert-butylisoxazol-3-yl)-4-(t...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2C9 using flourescent probe 7-methoxy-4-trifluoromethylcoumarinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50341008(4-[2-(1,1-Dioxo-1lambda*6*-thiomorpholin-4-yl)-ace...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP3A4 using flourescent probe 7-benzyloxyquinoline and 7-benzyloxy-4-(trifluoromethyl)-coumarin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50341023(CHEMBL1762293 | N-(5-tert-butylisoxazol-3-yl)-4-(t...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2D6 flourescent probe 3-[2-(N,N-diethyl-N-methylamino)ethyl]-7-methoxy-4-methylcoumarinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50341023(CHEMBL1762293 | N-(5-tert-butylisoxazol-3-yl)-4-(t...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP3A4 using flourescent probe 7-benzyloxyquinoline and 7-benzyloxy-4-(trifluoromethyl)-coumarin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50341008(4-[2-(1,1-Dioxo-1lambda*6*-thiomorpholin-4-yl)-ace...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2C9 using flourescent probe 7-methoxy-4-trifluoromethylcoumarinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50341008(4-[2-(1,1-Dioxo-1lambda*6*-thiomorpholin-4-yl)-ace...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2D6 flourescent probe 3-[2-(N,N-diethyl-N-methylamino)ethyl]-7-methoxy-4-methylcoumarinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50340991(4-(1,1-Dioxo-1lambda*6*-thiomorpholine-4-carbonyl)...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP3A4 using flourescent probe 7-benzyloxyquinoline and 7-benzyloxy-4-(trifluoromethyl)-coumarin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50340991(4-(1,1-Dioxo-1lambda*6*-thiomorpholine-4-carbonyl)...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2C9 using flourescent probe 7-methoxy-4-trifluoromethylcoumarinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50340991(4-(1,1-Dioxo-1lambda*6*-thiomorpholine-4-carbonyl)...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2D6 flourescent probe 3-[2-(N,N-diethyl-N-methylamino)ethyl]-7-methoxy-4-methylcoumarinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KK9C2MPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataIC50: 4.60E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042700(CHEMBL3353881)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50042591(CHEMBL3353862)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL
LigandPNGBDBM50042591(CHEMBL3353862)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50042700(CHEMBL3353881)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042585(CHEMBL3353864)copy SMILEScopy InChI
Affinity DataEC50:  0.200nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataEC50:  0.190nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042591(CHEMBL3353862)copy SMILEScopy InChI
Affinity DataEC50:  0.230nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataEC50:  30nMAssay Description:Displacement of [3H]-CP-55,940 from human CB1 receptor expressed in HEK293 cell membranes cells by SPAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataEC50:  3nMAssay Description:Displacement of [3H]-WIN-55,212-2 from human CB2 receptor expressed in HEK293 cell membranes cells by SPAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50006233(CHEMBL3235059)copy SMILEScopy InChI
Affinity DataEC50:  250nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50006259(CHEMBL3234706)copy SMILEScopy InChI
Affinity DataEC50:  53nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50006232(CHEMBL3235058)copy SMILEScopy InChI
Affinity DataEC50:  1.40E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50006233(CHEMBL3235059)copy SMILEScopy InChI
Affinity DataEC50:  0.0930nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50006259(CHEMBL3234706)copy SMILEScopy InChI
Affinity DataEC50:  0.0700nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50006232(CHEMBL3235058)copy SMILEScopy InChI
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042593(CHEMBL3352832)copy SMILEScopy InChI
Affinity DataEC50:  12nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042595(CHEMBL3353888)copy SMILEScopy InChI
Affinity DataEC50:  38nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042596(CHEMBL3353889)copy SMILEScopy InChI
Affinity DataEC50:  4.00E+3nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042597(CHEMBL3353890)copy SMILEScopy InChI
Affinity DataEC50:  390nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042598(CHEMBL3353891)copy SMILEScopy InChI
Affinity DataEC50:  2.20E+3nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042591(CHEMBL3353862)copy SMILEScopy InChI
Affinity DataEC50:  307nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042590(CHEMBL3353863)copy SMILEScopy InChI
Affinity DataEC50:  2.60E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042585(CHEMBL3353864)copy SMILEScopy InChI
Affinity DataEC50:  390nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042599(CHEMBL3353865)copy SMILEScopy InChI
Affinity DataEC50:  2.40E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042600(CHEMBL3353866)copy SMILEScopy InChI
Affinity DataEC50:  9.80E+4nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042648(CHEMBL3353867)copy SMILEScopy InChI
Affinity DataEC50:  1.01E+4nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042657(CHEMBL3353868)copy SMILEScopy InChI
Affinity DataEC50:  4.10E+4nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Evotec (UK) Ltd.

Curated by ChEMBL
LigandPNGBDBM50042658(CHEMBL3353869)copy SMILEScopy InChI
Affinity DataEC50:  4.90E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN75H1PubMed
Displayed 1 to 50 (of 225 total ) | Next | Last >>
Jump to: